Law360, New York (September 28, 2012, 3:00 PM ET) -- The U.S. Judicial Panel on Multidistrict Litigation on Thursday transferred five class actions alleging Wyeth LLC’s fen-phen diet drugs caused fatal lung disease into a Pennsylvania MDL over the objections of the plaintiffs, citing the record of swift resolution in that court.
Plaintiffs in the five actions — four in Delaware district court and one in the northern district of California — moved to vacate conditional transfer orders from the panel shipping their suits to Pennsylvania, arguing that pretrial proceedings in the Pennsylvania MDL had already...